Treatments of Psychiatric Disorders

Treatments of Psychiatric Disorders
复制标题

精神疾病的治疗

DOI:
--
复制
发表时间:
1995
期刊:
Nature Network Boston
影响因子:
--
通讯作者:
G. Gabbard
G. Gabbard
中科院分区:
--
文献类型:
--
作者:
G. Gabbard

文献摘要

被引文献

相似文献

卷1:第1部分一般考虑在精神病学治疗:精神和大脑在精神病学治疗中的性别问题在精神病学治疗中的文化问题。通常在婴儿期、儿童期或青春期首次诊断的疾病:智障人士的精神障碍学习障碍自闭症注意缺陷/多动障碍品行障碍抽动障碍消除障碍儿童和青少年焦虑症情绪障碍和自杀行为儿童创伤后应激障碍儿童强迫症药物滥用和药物使用障碍儿童期精神分裂症儿童睡眠障碍第三部分谵妄、痴呆、遗忘和其他认知障碍:一般医疗条件引起的谵妄,多种病因引起的谵妄,以及没有特别说明的谵妄物质引起的谵妄阿尔茨海默病血管性痴呆其他一般医疗条件引起的痴呆和多种病因引起的痴呆物质引起的持续性痴呆和物质引起的持续性遗忘障碍一般医疗条件引起的遗忘障碍和没有特别说明的遗忘障碍。第四部分药物相关疾病:治疗概述————治疗目标、患者评估、成瘾性药物的实验室和心理测试————酒精和其他抑郁药物————酗酒、苯二氮卓类药物和其他镇静催眠药物依赖、致幻剂和大麻————致幻剂、大麻使用、兴奋剂和相关药物————兴奋剂、苯环利定和氯胺酮滥用和依赖、俱乐部毒品、麻醉药品和阿片类药物成瘾的戒断和依赖药物治疗-解毒,阿片类药物,美沙酮维持,拮抗剂治疗-纳曲酮和相关药物的使用-个体治疗-精神动力学和物质相关疾病的治疗,酒精中毒的个体管理和心理治疗,物质使用障碍的个体心理治疗,复发预防,网络治疗小组和家庭治疗-精神活性物质使用障碍的小组治疗、酗酒的家庭治疗、药物滥用治疗特别方案和人群的家庭治疗-匿名酗酒者和其他十二步小组、住院治疗、社区治疗、治疗性社区治疗、双重诊断人群。第五部分:精神分裂症和其他精神疾病:精神分裂症的治疗目标精神分裂症和精神障碍的临床精神药理学精神分裂症组的个体心理治疗和精神分裂症的家庭心理治疗精神康复治疗设置-为精神分裂症或相关疾病患者提供连续的护理。第六部分情绪障碍:抗抑郁药和抗躁狂药物
Volume 1: Part 1 General Considerations in Psychiatric Treatment: Mind and Brain in Psychiatric Treatment Gender Issues in Psychiatric Treatment Cultural Issues in Psychiatric Treatment. Part 2 Disorders Usually First Diagnozed in Infancy, Childhood or Adolescence: Psychiatric Disorders in Mentally Retarded Persons Learning Disorders Autistic Disorder Attention-Deficit/Hyperactivity Disorder Conduct Disorder Tic Disorders Elimination Disorders Anxiety Disorders in Children and Adolescents Mood Disorders and Suicidal Behaviour Childhood Posttraumatic Stress Disorder Obsessive-Compulsive Disorder in Children Substance Abuse and Substance Use Disorders Childhood-Onset Schizophrenia Childhood Sleep Disorders. Part 3 Delirium, Dementia and Amnestic and Other Cognitive Disorders: Delirium Due to a General Medical Condition, Delirium Due to Multiple Aetiologies, and Delirium Not Otherwise Specified Substance-Induced Delirium Alzheimer's Disease Vascular Dementia Dementia Due to Other General Medical Conditions and Dementia Due to Multiple Aetiologies Substance-Induced Persisting Dementia and Substance-Induced Persisting Amnestic Disorder Amnestic Disorder Due to a General Medical Condition and Amnestic Disorder not Otherwise Specified. Part 4 Substance-Related Disorders: Overview of Treatment - Goals of Treatment, Assessment of Patients, Laboratory and Psychological Testing in Addiction Medicine Alcohol and Other Depressant Drugs - Alcoholism, Benzodiazepine and Other Sedative-Hypnotic Dependence The Hallucinogens and Cannabis - the Hallucinogens, Cannabis Use, Abuse and Dependence Stimulants and Related Drugs - Stimulants, Phencyclidine and Ketamine Abuse and Dependence, Club Drugs, Nicotine Withdrawal and Dependence Pharmacological Treatments for Narcotic and Opioid Addictions - Detoxification, Opioids, Methadone Maintenance, Antagonist Treatment - Use of Naltrexone and Related Medications Individual Treatment - Psychodynamics and the Treatment of Substance-Related Disorders, Individual Management and Psychotherapy for Alcoholism, Individual Psychotherapy for Substance Use Disorders, Relapse Prevention, Network Therapy Group and Family Treatments - Group Therapy for Psychoactive Substance Use Disorders, Family Therapy for Alcoholism, Family Therapy in Substance Abuse Treatment Special Programmes and Populations - Alcoholics Anonymous and Other Twelve-Step Groups, Inpatient Treatment, Community-Based Treatment, Therapeutic Community Treatment, Dual-Diagnosis Populations. Part 5 Schizophrenia and Other Psychotic Disorders: Treatment Targets in Schizophrenia Clinical Psychopharmacology of Schizophrenia and Psychotic Disorders Individual Psychotherapies of Schizophrenia Group and Family Psychotherapies of Schizophrenia Psychiatric Rehabilitation Treatment Settings - Providing a Continuum of Care for Patients with Schizophrenia or Related Disorders. Part 6 Mood Disorders: Antidepressant and Antimanic Medications Depressio